Clinical Trial Update: Effect of Oral Anti-diabetic Medication on Liver Fat in Subjects With Type II Diabetes and Non-alcoholic Fatty Liver [Phase 4]

View source ↗

Summary

Phase 4 clinical trial examining the impact of an oral anti-diabetic medication on liver fat in adults with type 2 diabetes and non-alcoholic fatty liver diseas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Fatty Liver Disease
• Nonalcoholic Steatohepatitis
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Getz Pharma | Conditions: Diabetes Mellitus, Type 2, NASH - Nonalcoholic Steatohepatitis | Phase 4 | Status: UNKNOWN